Authors: | Apolo, A. B.; Ballman, K. V.; Sonpavde, G.; Berg, S.; Kim, W. Y.; Parikh, R.; Teo, M. Y.; Sweis, R. F.; Geynisman, D. M.; Grivas, P.; Chatta, G.; Reichert, Z. R.; Kim, J. W.; Bilen, M. A.; McGregor, B.; Singh, P.; Tripathi, A.; Cole, S.; Simon, N.; Niglio, S.; Ley, L.; Cordes, L.; Srinivas, S.; Huang, J; Odegaard, M.; Watt, C; Petrylak, D; Hoffman‑Censits, J.; Wen, Y.; Hahn, O; Mitchell, C.; Tan, A.; Streicher, H.; Sharon, E.; Moon, H.; Woods, M.; Halabi, S.; Perez Burbano, G.; Morris, M. J.; Rosenberg, J. E. |
Article Title: | Adjuvant pembrolizumab versus observation in muscle-invasive urothelial carcinoma |
Journal Title: | New England Journal of Medicine |
Volume: | 392 |
Issue: | 1 |
ISSN: | 0028-4793 |
Publisher: | Massachusetts Medical Society |
Date Published: | 2025-01-02 |
Start Page: | 45 |
End Page: | 55 |
DOI: | 10.1056/NEJMoa2401726 |
PROVIDER: | EBSCOhost |
PROVIDER: | cinahl plus with full text |
PMCID: | PMC11698643 |
PUBMED: | 39282902 |
DOI/URL: | |
Notes: | The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in the PubMed record -- Source: CINAHL Plus with Full Text |